| 2922.49.05 | 00 | ￠/- α-Aminobenzeneacetic acid; 2-Amino-3-chlorobenzoic acid, methyl ester | kg | Free | | 15.4￠/kg + 50% |
| 2922.49.10 | 00 | m-Aminobenzoic acid, technical; p-Aminobenzoic acid; 3,5-Diaminobenzoic acid; 2-Ethylamino-5-sulfobenzoic acid; 3-(N-Ethylanilino)propionic acid, methyl ester; β-( β-Methoxyethoxyethyl)-4-aminobenzoate; Methyl anthranilate; and l-Phenylalanine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.49.40 | | Amino acids | | 4.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2922.49.40 | 20 | Glycine (Aminoacetic acid) | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ￠/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2922.50 | | Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: | | | | |
| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-￠/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ￠/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4￠/kg + 50% |
| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (￠/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924 | | Carboxyamide-function compounds; amide-function compounds of carbonic acid: | | | | |
| 2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.19.11 | | Amides | | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.19.11 | 10 | Acrylamide | kg | | | |
| 2924.19.11 | 20 | Dimethylformamide | kg | | | |
| 2924.19.11 | 30 | Methacrylamide | kg | | | |
| 2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid (N-acetylanthranilic acid) and its salts: | | | | |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.29.01 | 00 | p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamide | kg | Free | | 15.4￠/kg + 39.5% |
| 2924.29.03 | 00 | 3,5-Dinitro-o-toluamide | kg | Free | | 15.4￠/kg + 47.5% |
| 2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 34% |
